3,5-Dibromo-2-(trifluoromethyl)pyridin-4-amine, 500mg

3-Fluoro-4-(trifluoromethyl)benzonitrile, 97.0%, 1g

tert-butyl 3-(1H-1,2,3,4-tetrazol-5-yl)azetidine-1-carboxylate, 95%, 5g

(S)-Methyl 2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride, 95.0%, 10g

(3-hydroxybenzylidene)propanedinitrile, 1g

(R)-8-FLUORO-N-(1-OXO-1-(PYRROLIDIN-1-YL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-6-SULFONAMIDE HYDROCHLORIDE, 95%, 100mg

2-Ethyl-thioisonicotinamide, 96.0%, 1g

tert-Butyl 4-(methylamino)butylcarbamate, 95.0%, 1g

2-((2,2,10,10-Tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)acetic acid, 97%, 1g

N-[3-(1H-imidazol-1-yl)propyl]-4,6-dimethyl-1,3-benzothiazol-2-amine, 95.0%, 250mg

Mikroliterspritze MICROLITER® Serie 7000 Point Typ 2, 5,0 µl, 7105 KH, 1 Stück

1-chloro-4-[(4-chlorobenzene)sulfonyl]benzene, 98.0%, 1kg

6-Benzyloxyindole-3-carbaldehyde, 95.0%, 5g